Allworth Financial LP Grows Stock Holdings in Smith & Nephew plc (NYSE:SNN)

Allworth Financial LP grew its holdings in Smith & Nephew plc (NYSE:SNN) by 65.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,878 shares of the medical equipment provider’s stock after acquiring an additional 745 shares during the period. Allworth Financial LP’s holdings in Smith & Nephew were worth $51,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in SNN. Scharf Investments LLC grew its position in Smith & Nephew by 20.5% during the fourth quarter. Scharf Investments LLC now owns 2,980,334 shares of the medical equipment provider’s stock valued at $81,304,000 after buying an additional 506,474 shares during the period. PNC Financial Services Group Inc. increased its stake in shares of Smith & Nephew by 17.4% in the 3rd quarter. PNC Financial Services Group Inc. now owns 36,315 shares of the medical equipment provider’s stock valued at $900,000 after purchasing an additional 5,384 shares in the last quarter. Seed Wealth Management Inc. acquired a new position in Smith & Nephew in the 4th quarter worth about $213,000. American Century Companies Inc. grew its holdings in Smith & Nephew by 343.5% in the third quarter. American Century Companies Inc. now owns 2,364,037 shares of the medical equipment provider’s stock valued at $58,557,000 after purchasing an additional 1,830,965 shares during the period. Finally, Legacy Wealth Asset Management LLC increased its position in shares of Smith & Nephew by 3.8% in the third quarter. Legacy Wealth Asset Management LLC now owns 15,026 shares of the medical equipment provider’s stock valued at $372,000 after buying an additional 546 shares in the last quarter. 25.64% of the stock is owned by hedge funds and other institutional investors.

Smith & Nephew Price Performance

SNN stock opened at $23.77 on Friday. Smith & Nephew plc has a 12-month low of $21.52 and a 12-month high of $33.08. The business’s 50-day moving average is $26.75 and its 200 day moving average is $25.97. The company has a current ratio of 1.77, a quick ratio of 0.72 and a debt-to-equity ratio of 0.44.

Smith & Nephew Announces Dividend

The company also recently declared a semi-annual dividend, which will be paid on Wednesday, May 22nd. Stockholders of record on Tuesday, April 2nd will be paid a $0.462 dividend. This represents a dividend yield of 2.8%. The ex-dividend date of this dividend is Monday, April 1st.

Analyst Ratings Changes

Separately, StockNews.com raised shares of Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research note on Friday, March 15th. Three analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Smith & Nephew has a consensus rating of “Moderate Buy”.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.